A number of Randomised Controlled Trials (RCTs) have been conducted using the ODM to guide fluid management during surgery.

In March, 2018 the British Journal of Anaesthesia published the biggest ever positive study into the use of Deltex’s ODM to guide fluid/drug therapy during anaesthesia. Importantly this paper focuses on major surgery undertaken on patients considered to be at low-moderate haemodynamic risk. It can be found here.

The 420 patient, multicentre, randomised, controlled, researcher-blinded study is titled: Effect of goal-directed haemodynamic therapy on postoperative complications in low–moderate risk surgical patients: a multicentre randomised controlled trial (FEDORA trial), J.M. Calvo-Vecino, J. Ripollés-Melchor, M.G. Mythen, R. Casans-Francés, A. Balik, J.P. Artacho, E. Martínez-Hurtado, A. Serrano Romero, C. Fernández Pérez , S. Asuero de Lis

The discussion points out that “A haemodynamic optimization algorithm for management of low-moderate risk patients having major abdominal surgery significantly reduced postoperative complications in the 180 days after surgery. There was a decrease in AKI, acute respiratory distress syndrome, acute pulmonary oedema, pneumonia, and superficial or deep surgical site infection. LOS was shortened…”

FEDORA Brochure


Terminus Road | Chichester | PO19 8TX | United Kingdom

  • Enquiries: +44 1243 774837
  • Email: marketing@deltexmedical.com
  • Deltex App:


Registered in England & Wales Company No: 1691369